Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Tan

Showing results (631-640 of 634) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 634 results.
BMC Cancer|March 8, 2024
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trialChengcheng Fan, Xu Wang, Xiaoli Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer ImmunotherapyDavid A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Molecular Therapy. Methods & Clinical Development|July 1, 2017
Public Attitudes toward Gene Therapy in ChinaJiang-Hui Wang, Rong Wang, Jia Hui Lee, et al.
Cell Reports|July 8, 2023
Hydrogen sulfide functions as a micro-modulator bound at the copper active site of Cu/Zn-SOD to regulate the catalytic activity of the enzymeDong-Dong Wu, Sheng Jin, Ruo-Xiao Cheng, et al.
Pageof 64

Showing results (631-640 of 634) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 634 results.
BMC Cancer|March 8, 2024
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trialChengcheng Fan, Xu Wang, Xiaoli Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer ImmunotherapyDavid A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Molecular Therapy. Methods & Clinical Development|July 1, 2017
Public Attitudes toward Gene Therapy in ChinaJiang-Hui Wang, Rong Wang, Jia Hui Lee, et al.
Cell Reports|July 8, 2023
Hydrogen sulfide functions as a micro-modulator bound at the copper active site of Cu/Zn-SOD to regulate the catalytic activity of the enzymeDong-Dong Wu, Sheng Jin, Ruo-Xiao Cheng, et al.
Pageof 64